| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Collin M Bantle, C Tenley French, Jason E Cummings, Shankar Sadasivan, Kevin Tran, Richard A Slayden, Richard J Smeyne, Ronald B Tjalken. Manganese exposure in juvenile C57BL/6 mice increases glial inflammatory responses in the substantia nigra following infection with H1N1 influenza virus. PloS one. vol 16. issue 1. 2021-05-10. PMID:33493177. |
analyses of dopaminergic neurons, microglia and astrocytes in basal ganglia indicated that although there was no significant loss of dopaminergic neurons within the substantia nigra pars compacta, there was more pronounced activation of microglia and astrocytes in animals sequentially exposed to mn and h1n1, as well as altered patterns of histone acetylation. |
2021-05-10 |
2023-08-13 |
mouse |
| Rebekah C Evans, Emily L Twedell, Manhua Zhu, Jefferson Ascencio, Renshu Zhang, Zayd M Khali. Functional Dissection of Basal Ganglia Inhibitory Inputs onto Substantia Nigra Dopaminergic Neurons. Cell reports. vol 32. issue 11. 2021-05-04. PMID:32937133. |
functional dissection of basal ganglia inhibitory inputs onto substantia nigra dopaminergic neurons. |
2021-05-04 |
2023-08-13 |
Not clear |
| Zahra Jafari, Bryan E Kolb, Majid H Mohajeran. Auditory Dysfunction in Parkinson's Disease. Movement disorders : official journal of the Movement Disorder Society. vol 35. issue 4. 2021-04-27. PMID:32052894. |
improvement in auditory responses following dopaminergic therapies also indicates the presence of similar neurotransmitters (i.e., glutamate and dopamine) in the auditory system and basal ganglia. |
2021-04-27 |
2023-08-13 |
Not clear |
| Federica Campanelli, Daniela Laricchiuta, Giuseppina Natale, Gioia Marino, Valeria Calabrese, Barbara Picconi, Laura Petrosini, Paolo Calabresi, Veronica Ghiglier. Long-Term Shaping of Corticostriatal Synaptic Activity by Acute Fasting. International journal of molecular sciences. vol 22. issue 4. 2021-04-23. PMID:33671915. |
this basal ganglia nucleus is involved in habit formation and in eating behavior, especially that based on dopaminergic control of motivation for food in both humans and animals. |
2021-04-23 |
2023-08-13 |
mouse |
| Pragathi Priyadharsini Balasubramani, V Srinivasa Chakravarth. Bipolar oscillations between positive and negative mood states in a computational model of Basal Ganglia. Cognitive neurodynamics. vol 14. issue 2. 2021-04-02. PMID:32226561. |
phenomenological and network models of the basal ganglia extend that logic, and interpret bipolar oscillations in terms of the activity of dopaminergic and serotonergic projections on the cortico-basal ganglia network dynamics. |
2021-04-02 |
2023-08-13 |
Not clear |
| Mario Antonazzo, Sonia María Gomez-Urquijo, Luisa Ugedo, Teresa Morera-Herrera. Dopaminergic denervation impairs cortical motor and associative/limbic information processing through the basal ganglia and its modulation by the CB1 receptor. Neurobiology of disease. vol 148. 2021-03-23. PMID:33278598. |
dopaminergic denervation impairs cortical motor and associative/limbic information processing through the basal ganglia and its modulation by the cb1 receptor. |
2021-03-23 |
2023-08-13 |
rat |
| Giorgia Ponsi, Marina Scattolin, Riccardo Villa, Salvatore Maria Agliot. Human moral decision-making through the lens of Parkinson's disease. NPJ Parkinson's disease. vol 7. issue 1. 2021-03-20. PMID:33654110. |
parkinson's disease (pd) is a neurodegenerative disorder characterized by the loss of dopaminergic neurons in the basal ganglia (bg) and thalamocortical circuitry. |
2021-03-20 |
2023-08-13 |
human |
| Mohan K Ghanta, P Elango, Bhaskar L V K . Current Therapeutic Strategies and Perspectives for Neuroprotection in Parkinson's Disease. Current pharmaceutical design. vol 26. issue 37. 2021-03-19. PMID:32065086. |
parkinson's disease is a progressive neurodegenerative disorder of dopaminergic striatal neurons in basal ganglia. |
2021-03-19 |
2023-08-13 |
Not clear |
| R Mark Richardson, Krystof S Bankiewicz, Chadwick W Christine, Amber D Van Laar, Robert E Gross, Russell Lonser, Stewart A Factor, Sandra K Kostyk, Adrian P Kells, Bernard Ravina, Paul S Larso. Data-driven evolution of neurosurgical gene therapy delivery in Parkinson's disease. Journal of neurology, neurosurgery, and psychiatry. vol 91. issue 11. 2021-03-19. PMID:32732384. |
loss of nigrostriatal dopaminergic projection neurons is a key pathology in parkinson's disease, leading to abnormal function of basal ganglia motor circuits and the accompanying characteristic motor features. |
2021-03-19 |
2023-08-13 |
human |
| Marco Pozzi, Silvana Bertella, Erika Gatti, Gabriëlla G A M Peeters, Carla Carnovale, Stefania Zambrano, Maria Nobil. Emerging drugs for the treatment of attention-deficit hyperactivity disorder (ADHD). Expert opinion on emerging drugs. vol 25. issue 4. 2021-03-16. PMID:32938246. |
current pharmacological treatments for adhd are based on stimulant or non-stimulant medications, targeting dopaminergic and noradrenergic systems in the frontal cortex and dopaminergic system in the basal ganglia. |
2021-03-16 |
2023-08-13 |
Not clear |
| Tapan Behl, Gagandeep Kaur, Simona Bungau, Rishabh Jhanji, Arun Kumar, Vineet Mehta, Gokhan Zengin, Roxana Brata, Syed Shams Ul Hassan, Ovidiu Fratil. Distinctive Evidence Involved in the Role of Endocannabinoid Signalling in Parkinson's Disease: A Perspective on Associated Therapeutic Interventions. International journal of molecular sciences. vol 21. issue 17. 2021-02-24. PMID:32872273. |
endocannabinoids regulate the basal ganglia neuronal circuit pathways, synaptic plasticity, and motor functions via communication with dopaminergic, glutamatergic, and gabaergic signalling systems bidirectionally in pd. |
2021-02-24 |
2023-08-13 |
Not clear |
| Rafal Bogac. Dopamine role in learning and action inference. eLife. vol 9. 2021-02-22. PMID:32633715. |
in this framework, dopaminergic neurons projecting to different parts of the striatum encode errors in predictions made by the corresponding systems within the basal ganglia. |
2021-02-22 |
2023-08-13 |
Not clear |
| Ronghui Li, Xuxia Wang, Fuchun Lin, Tao Song, Xutao Zhu, Hao Le. Mapping accumulative whole-brain activities during environmental enrichment with manganese-enhanced magnetic resonance imaging. NeuroImage. vol 210. 2021-02-19. PMID:32004718. |
relative to the mice residing in a standard environment (se), the mice subjected to ee treatment had significantly enhanced regional memri signal intensities in the prefrontal cortex, somatosensory cortices, basal ganglia, amygdala, motor thalamus, lateral hypothalamus, ventral hippocampus and midbrain dopaminergic areas at the end of the 7-day exposure, likely attributing to enhanced mn |
2021-02-19 |
2023-08-13 |
mouse |
| Dimitri Ryczko, Swantje Grätsch, Michael H Alpert, Jackson J Cone, Jacquelin Kasemir, Angelina Ruthe, Philippe-Antoine Beauséjour, François Auclair, Mitchell F Roitman, Simon Alford, Réjean Dubu. Descending Dopaminergic Inputs to Reticulospinal Neurons Promote Locomotor Movements. The Journal of neuroscience : the official journal of the Society for Neuroscience. vol 40. issue 44. 2021-02-01. PMID:32998974. |
meso-diencephalic dopaminergic neurons are known to modulate locomotor behaviors through their ascending projections to the basal ganglia, which in turn project to the mesencephalic locomotor region, known to control locomotion in vertebrates. |
2021-02-01 |
2023-08-13 |
Not clear |
| Fumiaki Yokoi, Janneth Oleas, Hong Xing, Yuning Liu, Kelly M Dexter, Carly Misztal, Melinda Gerard, Iakov Efimenko, Patrick Lynch, Matthew Villanueva, Raul Alsina, Shiv Krishnaswamy, David E Vaillancourt, Yuqing L. Decreased number of striatal cholinergic interneurons and motor deficits in dopamine receptor 2-expressing-cell-specific Dyt1 conditional knockout mice. Neurobiology of disease. vol 134. 2021-01-13. PMID:31618684. |
d2r-expressing cells, such as the medium spiny neurons in the indirect pathway, striatal cholinergic interneurons, and dopaminergic neurons in the basal ganglia circuits, contribute to motor performance. |
2021-01-13 |
2023-08-13 |
mouse |
| Samuel Alberquilla, Aldo Gonzalez-Granillo, Eduardo Daniel Martín, Rosario Moratall. Dopamine regulates spine density in striatal projection neurons in a concentration-dependent manner. Neurobiology of disease. vol 134. 2021-01-13. PMID:31682992. |
dopaminergic afferents innervate spiny projection neurons (spns) in the striatum, maintaining basal ganglia activity. |
2021-01-13 |
2023-08-13 |
mouse |
| Qi-Wen Han, Yu-He Yuan, Nai-Hong Che. The therapeutic role of cannabinoid receptors and its agonists or antagonists in Parkinson's disease. Progress in neuro-psychopharmacology & biological psychiatry. vol 96. 2021-01-04. PMID:31442553. |
factors of the endocannabinoid system (ecs) are abundantly expressed in the neural circuits of basal ganglia, where they interact interactively with glutamatergic, γ-aminobutyric acid-ergic (gabaergic), and dopaminergic signaling systems. |
2021-01-04 |
2023-08-13 |
Not clear |
| Fillipe M de Araújo, Lorena Cuenca-Bermejo, Emiliano Fernández-Villalba, Silvia L Costa, Victor Diogenes A Silva, Maria Trinidad Herrer. Role of Microgliosis and NLRP3 Inflammasome in Parkinson's Disease Pathogenesis and Therapy. Cellular and molecular neurobiology. 2021-01-02. PMID:33387119. |
parkinson's disease (pd) is a neurodegenerative disorder marked primarily by motor symptoms such as rigidity, bradykinesia, postural instability and resting tremor associated with dopaminergic neuronal loss in the substantia nigra pars compacta (snpc) and deficit of dopamine in the basal ganglia. |
2021-01-02 |
2023-08-13 |
Not clear |
| Amnon A Berger, Ariel Winnick, Alexandra Welschmeyer, Alicia Kaneb, Kevin Berardino, Elyse M Cornett, Alan D Kaye, Omar Viswanath, Ivan Urit. Istradefylline to Treat Patients with Parkinson's Disease Experiencing "Off" Episodes: A Comprehensive Review. Neurology international. vol 12. issue 3. 2020-12-29. PMID:33302331. |
pd is caused by a loss of dopaminergic, cholinergic, serotonergic, and noradrenergic neurons in the central nervous system (cns), and peripherally; the syndromic parkinsonism symptoms of movement disorder, gait disorder, rigidity and tremor are mostly driven by the loss of these neurons in the basal ganglia. |
2020-12-29 |
2023-08-13 |
Not clear |
| Amnon A Berger, Ariel Winnick, Alexandra Welschmeyer, Alicia Kaneb, Kevin Berardino, Elyse M Cornett, Alan D Kaye, Omar Viswanath, Ivan Urit. Istradefylline to Treat Patients with Parkinson's Disease Experiencing "Off" Episodes: A Comprehensive Review. Neurology international. vol 12. issue 3. 2020-12-29. PMID:33302331. |
it promotes dopaminergic activity by antagonizing adenosine in the basal ganglia. |
2020-12-29 |
2023-08-13 |
Not clear |